{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:07:46Z","timestamp":1792552066874,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12264-026-01607-4","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T22:18:55Z","timestamp":1774217935000},"page":"1789-1808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuronal and Glial YAP\/TAZ in the Spinal Cord Contribute to the Development of Bone Cancer Pain in Mice"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2228-3079","authenticated-orcid":false,"given":"Bo","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5250-3761","authenticated-orcid":false,"given":"Xiaqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9141-6286","authenticated-orcid":false,"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4386-9868","authenticated-orcid":false,"given":"Xue-Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: A fatal attraction. Nat Rev Cancer 2011, 11: 411\u2013425.","journal-title":"Nat Rev Cancer"},{"key":"1607_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-3959(01)00324-4","volume":"93","author":"T Meuser","year":"2001","unstructured":"Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001, 93: 247\u2013257.","journal-title":"Pain"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","volume":"353","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999, 353: 1695\u20131700.","journal-title":"Lancet"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk S, Dickenson AH. Pain and nociception: Mechanisms of cancer-induced bone pain. J Clin Oncol 2014, 32: 1647\u20131654.","journal-title":"J Clin Oncol"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer 2002, 2: 201\u2013209.","journal-title":"Nat Rev Cancer"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jcb.20589","volume":"96","author":"MJ Goblirsch","year":"2005","unstructured":"Goblirsch MJ, Zwolak P, Clohisy DR. Advances in understanding bone cancer pain. J Cell Biochem 2005, 96: 682\u2013688.","journal-title":"J Cell Biochem"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","volume":"24","author":"LR Watkins","year":"2001","unstructured":"Watkins LR, Milligan ED, Maier SF. Glial activation: A driving force for pathological pain. Trends Neurosci 2001, 24: 450\u2013455.","journal-title":"Trends Neurosci"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science 2016, 354: 572\u2013577.","journal-title":"Science"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","volume":"20","author":"RR Ji","year":"2019","unstructured":"Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci 2019, 20: 667\u2013685.","journal-title":"Nat Rev Neurosci"},{"key":"1607_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110164","volume":"261","author":"C Ni","year":"2024","unstructured":"Ni C, Chen L, Hua B, Han Z, Xu L, Zhou Q. Epigenetic mechanisms of bone cancer pain. Neuropharmacology 2024, 261: 110164.","journal-title":"Neuropharmacology"},{"key":"1607_CR11","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1038\/s44319-024-00292-6","volume":"25","author":"C Xu","year":"2024","unstructured":"Xu C, Wang Y, Ni C, Xu M, Yin C, He Q, et al. Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models. EMBO Rep 2024, 25: 5429\u20135455.","journal-title":"EMBO Rep"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tibs.2020.08.008","volume":"46","author":"Z Wu","year":"2021","unstructured":"Wu Z, Guan KL. Hippo signaling in embryogenesis and development. Trends Biochem Sci 2021, 46: 51\u201363.","journal-title":"Trends Biochem Sci"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: Hippo signaling and beyond. Physiol Rev 2014, 94: 1287\u20131312.","journal-title":"Physiol Rev"},{"key":"1607_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dev.045500","volume":"138","author":"G Halder","year":"2011","unstructured":"Halder G, Johnson RL. Hippo signaling: Growth control and beyond. Development 2011, 138: 9\u201322.","journal-title":"Development"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tcb.2015.05.002","volume":"25","author":"CG Hansen","year":"2015","unstructured":"Hansen CG, Moroishi T, Guan KL. YAP and TAZ: A nexus for Hippo signaling and beyond. Trends Cell Biol 2015, 25: 499\u2013513.","journal-title":"Trends Cell Biol"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell 2016, 29: 783\u2013803.","journal-title":"Cancer Cell"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coph.2016.05.002","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Battilana G, Cordenonsi M, Piccolo S. YAP\/TAZ as therapeutic targets in cancer. Curr Opin Pharmacol 2016, 29: 26\u201333.","journal-title":"Curr Opin Pharmacol"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/cercor\/bhv292","volume":"26","author":"Z Huang","year":"2016","unstructured":"Huang Z, Wang Y, Hu G, Zhou J, Mei L, Xiong WC. YAP is a critical inducer of SOCS3, preventing reactive astrogliosis. Cereb Cortex 2016, 26: 2299\u20132310.","journal-title":"Cereb Cortex"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbi.2015.12.016","volume":"55","author":"S Zhao","year":"2016","unstructured":"Zhao S, Yin J, Zhou L, Yan F, He Q, Huang L, et al. Hippo\/MST1 signaling mediates microglial activation following acute cerebral ischemia-reperfusion injury. Brain Behav Immun 2016, 55: 236\u2013248.","journal-title":"Brain Behav Immun"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1089\/dna.2019.5308","volume":"39","author":"J Qing","year":"2020","unstructured":"Qing J, Liu X, Wu Q, Zhou M, Zhang Y, Mazhar M, et al. Hippo\/YAP pathway plays a critical role in effect of GDNF against a\u03b2-induced inflammation in microglial cells. DNA Cell Biol 2020, 39: 1064\u20131071.","journal-title":"DNA Cell Biol"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.1523\/JNEUROSCI.0800-16.2016","volume":"36","author":"N Xu","year":"2016","unstructured":"Xu N, Wu MZ, Deng XT, Ma PC, Li ZH, Liang L, et al. Inhibition of YAP\/TAZ activity in spinal cord suppresses neuropathic pain. J Neurosci 2016, 36: 10128\u201310140.","journal-title":"J Neurosci"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006, 355: 1432\u20131444.","journal-title":"N Engl J Med"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-023-01319-y","volume":"9","author":"L Wei","year":"2023","unstructured":"Wei L, Ma X, Hou Y, Zhao T, Sun R, Qiu C, et al. Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discov 2023, 9: 30.","journal-title":"Cell Death Discov"},{"key":"1607_CR24","doi-asserted-by":"crossref","unstructured":"Shen Y, Wang X, Liu Y, Singhal M, G\u00fcrka\u015flar C, Valls AF, et al. STAT3-YAP\/TAZ signaling in endothelial cells promotes tumor angiogenesis. Sci Signal 2021, 14: eabj8393.","DOI":"10.1126\/scisignal.abj8393"},{"key":"1607_CR25","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1681\/ASN.2015050499","volume":"27","author":"SG Szeto","year":"2016","unstructured":"Szeto SG, Narimatsu M, Lu M, He X, Sidiqi AM, Tolosa MF, et al. YAP\/TAZ are mechanoregulators of TGF-\u03b2-smad signaling and renal fibrogenesis. J Am Soc Nephrol 2016, 27: 3117\u20133128.","journal-title":"J Am Soc Nephrol"},{"key":"1607_CR26","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1074\/jbc.M110.139915","volume":"286","author":"E Donohue","year":"2011","unstructured":"Donohue E, Tovey A, Vogl AW, Arns S, Sternberg E, Young RN, et al. Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J Biol Chem 2011, 286: 7290\u20137300.","journal-title":"J Biol Chem"},{"key":"1607_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114964","volume":"9","author":"E Donohue","year":"2014","unstructured":"Donohue E, Balgi AD, Komatsu M, Roberge M. Induction of covalently crosslinked p62 oligomers with reduced binding to polyubiquitinated proteins by the autophagy inhibitor verteporfin. PLoS One 2014, 9: e114964.","journal-title":"PLoS One"},{"key":"1607_CR28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2014.11.003","volume":"159","author":"B Duan","year":"2014","unstructured":"Duan B, Cheng L, Bourane S, Britz O, Padilla C, Garcia-Campmany L, et al. Identification of spinal circuits transmitting and gating mechanical pain. Cell 2014, 159: 1417\u20131432.","journal-title":"Cell"},{"key":"1607_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell 2014, 158: 157\u2013170.","journal-title":"Cell"},{"key":"1607_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","volume":"43","author":"A Takahashi","year":"2011","unstructured":"Takahashi A, Tsutsumi R, Kikuchi I, Obuse C, Saito Y, Seidi A, et al. SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell 2011, 43: 45\u201356.","journal-title":"Mol Cell"},{"key":"1607_CR31","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.devcel.2013.08.013","volume":"26","author":"R Tsutsumi","year":"2013","unstructured":"Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell 2013, 26: 658\u2013665.","journal-title":"Dev Cell"},{"key":"1607_CR32","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1097\/j.pain.0000000000000366","volume":"156","author":"S Liu","year":"2015","unstructured":"Liu S, Liu YP, Huang ZJ, Zhang YK, Song AA, Ma PC, et al. Wnt\/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats. Pain 2015, 156: 2572\u20132584.","journal-title":"Pain"},{"key":"1607_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cell.2015.12.029","volume":"164","author":"B Liu","year":"2016","unstructured":"Liu B, Zheng Y, Yin F, Yu J, Silverman N, Pan D. Toll receptor-mediated hippo signaling controls innate immunity in Drosophila. Cell 2016, 164: 406\u2013419.","journal-title":"Cell"},{"key":"1607_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Lu X, Dey P, Deng P, Wu CC, Jiang S, et al. Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov 2016, 6: 80\u201395.","journal-title":"Cancer Discov"},{"key":"1607_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ni.3744","volume":"18","author":"S Wang","year":"2017","unstructured":"Wang S, Xie F, Chu F, Zhang Z, Yang B, Dai T, et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKK\u025b-mediated phosphorylation. Nat Immunol 2017, 18: 733\u2013743.","journal-title":"Nat Immunol"},{"key":"1607_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fimmu.2020.00323","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang S, Zhou L, Ling L, Meng X, Chu F, Zhang S, et al. The crosstalk between hippo-YAP pathway and innate immunity. Front Immunol 2020, 11: 323.","journal-title":"Front Immunol"},{"key":"1607_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gad.296640.117","volume":"31","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Bristow CA, Dey P, Rai K, Perets R, Ramirez-Cardenas A, et al. PRKCI promotes immune suppression in ovarian cancer. Genes Dev 2017, 31: 1109\u20131121.","journal-title":"Genes Dev"},{"key":"1607_CR38","doi-asserted-by":"crossref","unstructured":"Hagenbeek TJ, Webster JD, Kljavin NM, Chang MT, Pham T, Lee HJ, et al. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Sci Signal 2018, 11: eaaj1757.","DOI":"10.1126\/scisignal.aaj1757"},{"key":"1607_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrn2947","volume":"11","author":"AJ Todd","year":"2010","unstructured":"Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 2010, 11: 823\u2013836.","journal-title":"Nat Rev Neurosci"},{"key":"1607_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","volume":"10","author":"EC Dresselhaus","year":"2019","unstructured":"Dresselhaus EC, Meffert MK. Cellular specificity of NF-\u03baB function in the nervous system. Front Immunol 2019, 10: 1043.","journal-title":"Front Immunol"},{"key":"1607_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells10010184","volume":"10","author":"K Masliantsev","year":"2021","unstructured":"Masliantsev K, Karayan-Tapon L, Guichet PO. Hippo signaling pathway in gliomas. Cells 2021, 10: 184.","journal-title":"Cells"},{"key":"1607_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10571-019-00762-9","volume":"40","author":"T Ouyang","year":"2020","unstructured":"Ouyang T, Meng W, Li M, Hong T, Zhang N. Recent advances of the hippo\/YAP signaling pathway in brain development and glioma. Cell Mol Neurobiol 2020, 40: 495\u2013510.","journal-title":"Cell Mol Neurobiol"},{"key":"1607_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.brainres.2013.08.049","volume":"1535","author":"N Li","year":"2013","unstructured":"Li N, Lim G, Chen L, McCabe MF, Kim H, Zhang S, et al. Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats. Brain Res 2013, 1535: 137\u2013147.","journal-title":"Brain Res"},{"key":"1607_CR44","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/\u03b2-catenin signaling and disease. Cell 2012, 149: 1192\u20131205.","journal-title":"Cell"},{"key":"1607_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 2017, 169: 985\u2013999.","journal-title":"Cell"},{"key":"1607_CR46","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, et al. Alternative Wnt signaling activates YAP\/TAZ. Cell 2015, 162: 780\u2013794.","journal-title":"Cell"},{"key":"1607_CR47","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, et al. Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell 2002, 108: 837\u2013847.","journal-title":"Cell"},{"key":"1607_CR48","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/emboj\/18.9.2401","volume":"18","author":"M Kitagawa","year":"1999","unstructured":"Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 1999, 18: 2401\u20132410.","journal-title":"EMBO J"},{"key":"1607_CR49","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16: 3797\u20133804.","journal-title":"EMBO J"},{"key":"1607_CR50","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1172\/JCI65364","volume":"123","author":"YK Zhang","year":"2013","unstructured":"Zhang YK, Huang ZJ, Liu S, Liu YP, Song AA, Song XJ. WNT signaling underlies the pathogenesis of neuropathic pain in rodents. J Clin Invest 2013, 123: 2268\u20132286.","journal-title":"J Clin Invest"},{"key":"1607_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-025-02391-x","volume":"24","author":"F Xie","year":"2025","unstructured":"Xie F, Lyu Y, Chen B, Leung HW, Yu P, Feng T, et al. STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis. Mol Cancer 2025, 24: 186.","journal-title":"Mol Cancer"},{"key":"1607_CR52","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1038\/s41467-018-07022-2","volume":"9","author":"Y Deng","year":"2018","unstructured":"Deng Y, Lu J, Li W, Wu A, Zhang X, Tong W, et al. Reciprocal inhibition of YAP\/TAZ and NF-\u03baB regulates osteoarthritic cartilage degradation. Nat Commun 2018, 9: 4564.","journal-title":"Nat Commun"},{"key":"1607_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41420-020-0274-3","volume":"6","author":"Y Gui","year":"2020","unstructured":"Gui Y, Hou Q, Lu Q, Dai C, Li J. Loss of Rictor in tubular cells exaggerates lipopolysaccharide induced renal inflammation and acute kidney injury via Yap\/Taz-NF-\u03baB axis. Cell Death Discov 2020, 6: 40.","journal-title":"Cell Death Discov"},{"key":"1607_CR54","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1242\/dev.130658","volume":"143","author":"Z Huang","year":"2016","unstructured":"Huang Z, Hu J, Pan J, Wang Y, Hu G, Zhou J, et al. YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation. Development 2016, 143: 2398\u20132409.","journal-title":"Development"},{"key":"1607_CR55","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1523\/JNEUROSCI.4487-15.2016","volume":"36","author":"Z Huang","year":"2016","unstructured":"Huang Z, Sun D, Hu JX, Tang FL, Lee DH, Wang Y, et al. Neogenin promotes BMP2 activation of YAP and Smad1 and enhances astrocytic differentiation in developing mouse neocortex. J Neurosci 2016, 36: 5833\u20135849.","journal-title":"J Neurosci"},{"key":"1607_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116480","volume":"279","author":"Q Xue","year":"2024","unstructured":"Xue Q, Yan Y, Zhang K, Zhang H, Zhao Y. Exposure to microcystin-LR promotes astrocyte proliferation both in vitro and in vivo via Hippo signaling pathway. Ecotoxicol Environ Saf 2024, 279: 116480.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1607_CR57","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.7150\/thno.60031","volume":"11","author":"Q Wu","year":"2021","unstructured":"Wu Q, Miao X, Zhang J, Xiang L, Li X, Bao X, et al. Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-\u03b2 signaling. Theranostics 2021, 11: 8480\u20138499.","journal-title":"Theranostics"},{"key":"1607_CR58","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s13311-020-00905-7","volume":"17","author":"CR Donnelly","year":"2020","unstructured":"Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, et al. Central nervous system targets: Glial cell mechanisms in chronic pain. Neurotherapeutics 2020, 17: 846\u2013860.","journal-title":"Neurotherapeutics"},{"key":"1607_CR59","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12264-022-00961-3","volume":"39","author":"HJ Lu","year":"2023","unstructured":"Lu HJ, Gao YJ. Astrocytes in chronic pain: Cellular and molecular mechanisms. Neurosci Bull 2023, 39: 425\u2013439.","journal-title":"Neurosci Bull"},{"key":"1607_CR60","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2017, 2: 17023.","journal-title":"Signal Transduct Target Ther"},{"key":"1607_CR61","doi-asserted-by":"publisher","first-page":"55633","DOI":"10.1074\/jbc.M409825200","volume":"279","author":"H Buss","year":"2004","unstructured":"Buss H, D\u00f6rrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{Epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 2004, 279: 55633\u201355643.","journal-title":"J Biol Chem"},{"key":"1607_CR62","doi-asserted-by":"crossref","unstructured":"Cai X, Warburton C, Perez OF, Wang Y, Ho L, Finelli C, et al. Hippo-PKC\u03b6-NF\u03baB signaling axis: A druggable modulator of chondrocyte responses to mechanical stress. iScience 2024, 27: 109983.","DOI":"10.1016\/j.isci.2024.109983"},{"key":"1607_CR63","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cellsig.2012.12.006","volume":"25","author":"C Halleskog","year":"2013","unstructured":"Halleskog C, Schulte G. Pertussis toxin-sensitive heterotrimeric G(\u03b1i\/o) proteins mediate WNT\/\u03b2-catenin and WNT\/ERK1\/2 signaling in mouse primary microglia stimulated with purified WNT-3A. Cell Signal 2013, 25: 822\u2013828.","journal-title":"Cell Signal"},{"key":"1607_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/glia.21081","volume":"59","author":"C Halleskog","year":"2011","unstructured":"Halleskog C, Mulder J, Dahlstr\u00f6m J, Mackie K, Hortob\u00e1gyi T, Tanila H, et al. WNT signaling in activated microglia is proinflammatory. Glia 2011, 59: 119\u2013131.","journal-title":"Glia"},{"key":"1607_CR65","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1073\/pnas.1118754109","volume":"109","author":"C Yang","year":"2012","unstructured":"Yang C, Iyer RR, Yu ACH, Yong RL, Park DM, Weil RJ, et al. \u03b2-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc Natl Acad Sci U S A 2012, 109: 6963\u20136968.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01607-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:03:39Z","timestamp":1785485019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-026-01607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01607-4","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}